Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|April 14, 2016
Developmental Toxicity Studies with Pregabalin in Rats: Significance of Alterations in Skull Bone MorphologyDennis C Morse, Judith W Henck, Steven A BaileyEnvironmental Health Perspectives|February 3, 2004
Hazard identification and predictability of children's health risk from animal dataLaRonda L Morford, Judith W Henck, William J Breslin, et al.International Journal of Toxicology|July 7, 2016
Current Topics in Postnatal Behavioral TestingJudith W Henck, Ikram Elayan, Charles Vorhees, et al.Toxicologic Pathology|November 3, 2005
Androgen dependent mammary gland virilism in rats given the selective estrogen receptor modulator LY2066948 hydrochlorideDaniel G Rudmann, Ilene R Cohen, Michelle R Robbins, et al.Current Drug Safety|August 12, 2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial dataJoachim Wernicke, Beth Pangallo, Fujun Wang, et al.Journal of Medicinal Chemistry|December 20, 2015
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle AtrophyAshraf Saeed, Grant M Vaught, Kostas Gavardinas, et al.Endocrinology|July 9, 2005
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulationAndrew G Geiser, Conrad W Hummel, Michael W Draper, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.Pageof 1